Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil

PURPOSE The objective of this review was to address the barriers limiting access to genetic cancer risk assessment and genetic testing for individuals with suspected hereditary breast and ovarian cancer (HBOC) through a review of the diagnosis and management steps of HBOC. METHODS A selected panel o...

Full description

Bibliographic Details
Main Authors: Maria Isabel Achatz, Maira Caleffi, Rodrigo Guindalini, Renato Moretti Marques, Angelica Nogueira-Rodrigues, Patricia Ashton-Prolla
Format: Article
Language:English
Published: American Society of Clinical Oncology 2020-11-01
Series:JCO Global Oncology
Online Access:https://ascopubs.org/doi/10.1200/JGO.19.00170
_version_ 1828915724259688448
author Maria Isabel Achatz
Maira Caleffi
Rodrigo Guindalini
Renato Moretti Marques
Angelica Nogueira-Rodrigues
Patricia Ashton-Prolla
author_facet Maria Isabel Achatz
Maira Caleffi
Rodrigo Guindalini
Renato Moretti Marques
Angelica Nogueira-Rodrigues
Patricia Ashton-Prolla
author_sort Maria Isabel Achatz
collection DOAJ
description PURPOSE The objective of this review was to address the barriers limiting access to genetic cancer risk assessment and genetic testing for individuals with suspected hereditary breast and ovarian cancer (HBOC) through a review of the diagnosis and management steps of HBOC. METHODS A selected panel of Brazilian experts in fields related to HBOC was provided with a series of relevant questions to address before the multiday conference. During this conference, each narrative was discussed and edited by the entire group, through numerous drafts and rounds of discussion, until a consensus was achieved. RESULTS The authors propose specific and realistic recommendations for improving access to early diagnosis, risk management, and cancer care of HBOC specific to Brazil. Moreover, in creating these recommendations, the authors strived to address all the barriers and impediments mentioned in this article. CONCLUSION There is a great need to expand hereditary cancer testing and counseling in Brazil, and changing current policies is essential to accomplishing this goal. Increased knowledge and awareness, together with regulatory actions to increase access to this technology, have the potential to improve patient care and prevention and treatment efforts for patients with cancer across the country.
first_indexed 2024-12-13T20:19:23Z
format Article
id doaj.art-a9a11f3228a54589a1af60abb0fbbeb1
institution Directory Open Access Journal
issn 2687-8941
language English
last_indexed 2024-12-13T20:19:23Z
publishDate 2020-11-01
publisher American Society of Clinical Oncology
record_format Article
series JCO Global Oncology
spelling doaj.art-a9a11f3228a54589a1af60abb0fbbeb12022-12-21T23:32:44ZengAmerican Society of Clinical OncologyJCO Global Oncology2687-89412020-11-01643945210.1200/JGO.19.00170Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in BrazilMaria Isabel Achatz0Maira Caleffi1Rodrigo Guindalini2Renato Moretti Marques3Angelica Nogueira-Rodrigues4Patricia Ashton-Prolla5Centro de Oncologia, Hospital Sírio-Libanês, São Paulo, BrazilNucleo Mama Porto Alegre and Associação Hospitalar Moinhos de Vento, Porto Alegre, BrazilOncologia D’or, Rede D’or São Luiz, BrazilPrograma da Saúde da Mulher, Hospital Israelita Albert Einstein, São Paulo, BrazilUniversidade Federal de Minas Gerais, Belo Horizonte, BrazilDepartmento de Genética, Universidade Federal do Rio Grande do SulPURPOSE The objective of this review was to address the barriers limiting access to genetic cancer risk assessment and genetic testing for individuals with suspected hereditary breast and ovarian cancer (HBOC) through a review of the diagnosis and management steps of HBOC. METHODS A selected panel of Brazilian experts in fields related to HBOC was provided with a series of relevant questions to address before the multiday conference. During this conference, each narrative was discussed and edited by the entire group, through numerous drafts and rounds of discussion, until a consensus was achieved. RESULTS The authors propose specific and realistic recommendations for improving access to early diagnosis, risk management, and cancer care of HBOC specific to Brazil. Moreover, in creating these recommendations, the authors strived to address all the barriers and impediments mentioned in this article. CONCLUSION There is a great need to expand hereditary cancer testing and counseling in Brazil, and changing current policies is essential to accomplishing this goal. Increased knowledge and awareness, together with regulatory actions to increase access to this technology, have the potential to improve patient care and prevention and treatment efforts for patients with cancer across the country.https://ascopubs.org/doi/10.1200/JGO.19.00170
spellingShingle Maria Isabel Achatz
Maira Caleffi
Rodrigo Guindalini
Renato Moretti Marques
Angelica Nogueira-Rodrigues
Patricia Ashton-Prolla
Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil
JCO Global Oncology
title Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil
title_full Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil
title_fullStr Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil
title_full_unstemmed Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil
title_short Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil
title_sort recommendations for advancing the diagnosis and management of hereditary breast and ovarian cancer in brazil
url https://ascopubs.org/doi/10.1200/JGO.19.00170
work_keys_str_mv AT mariaisabelachatz recommendationsforadvancingthediagnosisandmanagementofhereditarybreastandovariancancerinbrazil
AT mairacaleffi recommendationsforadvancingthediagnosisandmanagementofhereditarybreastandovariancancerinbrazil
AT rodrigoguindalini recommendationsforadvancingthediagnosisandmanagementofhereditarybreastandovariancancerinbrazil
AT renatomorettimarques recommendationsforadvancingthediagnosisandmanagementofhereditarybreastandovariancancerinbrazil
AT angelicanogueirarodrigues recommendationsforadvancingthediagnosisandmanagementofhereditarybreastandovariancancerinbrazil
AT patriciaashtonprolla recommendationsforadvancingthediagnosisandmanagementofhereditarybreastandovariancancerinbrazil